Back to News
Market Impact: 0.65

Should You Buy Newmont Stock After a 39% Rally in 6 Months?

NEMGOLDAEMKGCNDAQ
Company FundamentalsCommodities & Raw MaterialsMarket Technicals & FlowsCorporate EarningsM&A & RestructuringCapital Returns (Dividends / Buybacks)Trade Policy & Supply ChainGeopolitics & War
Should You Buy Newmont Stock After a 39% Rally in 6 Months?

Newmont Corporation (NEM) shares have rallied 39.2% over the past six months, outperforming the industry and S&P 500, primarily driven by a surge in gold prices amid geopolitical and trade uncertainties. The company demonstrates strong bullish technicals and robust fundamentals, including strategic growth projects, the successful integration of Newcrest Mining yielding $500 million in annual synergies, and a $3 billion non-core asset divestiture program aimed at reinforcing its balance sheet and enhancing shareholder returns. With $8.8 billion in liquidity, a 162% year-over-year increase in Q1 2025 operating cash flow, and rising earnings estimates, Newmont is well-positioned to capitalize on favorable gold market conditions, presenting a compelling investment case.

Analysis

Newmont Corporation (NEM) has demonstrated significant stock appreciation, rallying 39.2% over the past six months and outperforming both its industry and the S&P 500. This performance is primarily propelled by a surge in gold prices, which have climbed approximately 27% this year to over $3,300 per ounce amidst heightened geopolitical and trade tensions. The company's fundamental strength is underpinned by strategic initiatives, including the successful integration of Newcrest Mining, which is already delivering $500 million in annual run-rate synergies. Concurrently, Newmont is executing a rigorous asset streamlining program, targeting $3 billion in after-tax cash proceeds in 2025 from non-core divestitures to fortify its balance sheet and focus on high-return Tier 1 assets. Financially, the company is robust, reporting a 162% year-over-year increase in Q1 operating cash flow to approximately $2 billion, a record $1.2 billion in free cash flow, and a strong liquidity position of $8.8 billion. This financial health supports a disciplined capital allocation strategy, evidenced by $1 billion in debt reduction and $1 billion in shareholder returns since the start of 2025. Bullish technical indicators, such as a "golden crossover" and trading above key moving averages, coupled with rising earnings estimates projecting 31.3% YoY growth for 2025, suggest continued positive momentum. The stock's forward P/E of 12.24X remains at a slight discount to the industry average, presenting a compelling valuation case.